- 专利标题： TETRALINE AND INDANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY
-
申请号： US13207160申请日： 2011-08-10
-
公开(公告)号： US20120040947A1公开(公告)日： 2012-02-16
- 发明人: Frauke Pohlki , Udo Lange , Wilhelm Amberg , Michael Ochse , Berthold Behl , Charles W. Hutchins
- 申请人： Frauke Pohlki , Udo Lange , Wilhelm Amberg , Michael Ochse , Berthold Behl , Charles W. Hutchins
- 申请人地址： US IL Abbott Park DE Wiesbaden
- 专利权人： Abbott Laboratories,Abbott GmbH & Co. KG
- 当前专利权人： Abbott Laboratories,Abbott GmbH & Co. KG
- 当前专利权人地址： US IL Abbott Park DE Wiesbaden
- 主分类号： A61K31/397
- IPC分类号： A61K31/397 ; A61K31/417 ; A61K31/415 ; A61K31/18 ; A61K31/4178 ; A61P25/00 ; C07D403/10 ; C07D231/18 ; C07D205/04 ; C07C311/14 ; A61P25/18 ; A61K31/4155 ; C07D233/84
摘要：
The present invention relates to tetraline and indane derivatives of the formula (I) or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such tetraline and indane derivatives, and the use of such tetraline and indane derivatives for therapeutic purposes. The tetraline and indane derivatives are GlyT1 inhibitors.
公开/授权文献
信息查询
